Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 102.01M P/E - EPS this Y 21.00% Ern Qtrly Grth -
Income -112.67M Forward P/E -0.82 EPS next Y -11.70% 50D Avg Chg -2.00%
Sales 6.29M PEG - EPS past 5Y - 200D Avg Chg -6.00%
Dividend N/A Price/Book 0.45 EPS next 5Y - 52W High Chg -69.00%
Recommedations 2.00 Quick Ratio 7.01 Shares Outstanding 60.10M 52W Low Chg 47.00%
Insider Own 19.59% ROA -28.83% Shares Float 43.75M Beta 1.83
Inst Own 44.66% ROE -55.84% Shares Shorted/Prior 662.73K/667.84K Price 1.77
Gross Margin 100.00% Profit Margin - Avg. Volume 334,861 Target Price 4.25
Oper. Margin -994.36% Earnings Date May 8 Volume 204,128 Change -1.12%
About Kronos Bio, Inc.

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutics for various cancer and other serious diseases in the United States. Its lead product candidates are KB-0742, an oral cyclin dependent kinase 9 inhibitor for the treatment of MYC-amplified solid tumors, which is in phase 2 clinical trial; and KB-9558, a core oncogenic transcription factor that drives multiple myeloma. The company was incorporated in 2017 and is headquartered in San Mateo, California.

Kronos Bio, Inc. News
04/24/24 Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
11:00 AM Kronos Bio (KRON) Upgraded to Buy: What Does It Mean for the Stock?
03/21/24 Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results
03/07/24 Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway
03/05/24 Kronos Bio To Present Three Posters at AACR 2024 Annual Meeting
04:05 PM Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference
01/25/24 Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement
01/01/24 We're Keeping An Eye On Kronos Bio's (NASDAQ:KRON) Cash Burn Rate
12/18/23 Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate
12/04/23 Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
04:05 PM Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare Conference
11/20/23 Kronos Bio Up 47%, Insider Buyers Are Up 31%
11/13/23 Kronos Bio, Inc. (KRON) Reports Q3 Loss, Lags Revenue Estimates
11/13/23 Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial Results
11/02/23 Kronos Bio Announces Plan to Optimize Resource Allocation, Restructure and Contain Costs Following Positive Preliminary Clinical Data from its KB-0742 Phase 1/2 Study
11/02/23 Kronos Bio Presents Positive Preliminary Data from the Phase 1 Dose Escalation Portion of the Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual Meeting
07:00 AM Kronos Bio To Present Positive Preliminary Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual Meeting
10/13/23 Kronos Bio Presents Positive Preliminary Data from Phase 1 Dose Escalation Portion of Phase 1/2 KB-0742 Study at AACR-NCI-EORTC
10/04/23 Kronos Bio To Present Interim Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at AACR-NCI-EORTC and Host Virtual Investor Event on October 13
08/17/23 Kronos Bio Announces Departure of Chief Financial Officer and Head of Corporate Development
KRON Chatroom

User Image HamburgerTim Posted - 15 hours ago

$KRON this bled back to $1 for no reason.? Reload...

User Image TheGhostOfEd Posted - 18 hours ago

$KRON One penny away from a nice doji on the weekly......

User Image flyinghollaender Posted - 19 hours ago

$XFOR what a roller coaster. We'll see how it ends. I have a good feeling. Still holding 5 thousand shares with avg. 0.65 . Already sold 15k shares with an avg price of 1.33$. $ADAP $HUMA bright weeks & months ahead! $MIST planning to use my earnings or losses from XFOR to buy more. $KRON will buy more at a later state.

User Image Digital_Waffle_Pirate Posted - 19 hours ago

$KRON Well here you go - in addition to shit response, it appears that SYK targeting HOX/MEIS elevation was the wrong approach for FLT3 in the first place. Immaterial to where we are now, but still a bum deal... they should offload ENTO and LANRA for pennies on the dollar if they can get them... sell em to Incyte since there seemed to be a preclinical rationale for a combo with ruxolitinib. https://www.cell.com/iscience/fulltext/S2589-0042(24)00798-3?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2589004224007983%3Fshowall%3Dtrue

User Image Digital_Waffle_Pirate Posted - 22 hours ago

$KRON An invisibility cloak for would-be cancers. Well ya don't sayyyyy... I wonder what company with roots out of the MIT TLO does a really good job of mapping transcriptional regulatory network and identifying critical co-factors of intrinsically disordered TFs? "But transcription factors such as the one encoded by the SOX17 gene are considered difficult to target using drugs, in part because of their structure. The researchers now plan to identify other proteins that this transcription factor interacts with, in hopes that it might be easier to block some of those interactions." https://www.technologyreview.com/2024/04/23/1090416/an-invisibility-cloak-for-would-be-cancers/

User Image TheGhostOfEd Posted - 23 hours ago

$KRON Back in with 50k shares. Will double up below .75 if we get there.

User Image Digital_Waffle_Pirate Posted - 23 hours ago

$KRON For those looking for a filing from Norbert today (I'm not sure I'm one of them) it is worth mentioning that this would look like his November buying... "and on the third day he returned the stock to compliance". Oh boy.... did I just compare Norbert to Jesus? heeeeeeeeeelllpp!

User Image telomerase Posted - 23 hours ago

$KRON I'm glad that we have A New Hope (Episode 4) now, because the old story was a lot less funny than "we can haz ds RNA and cancer cells would care". Old Story: "By inhibiting CDK9, KB-0742 prevents the phosphorylation of RNA polymerase II. This results in the inhibition of transcription elongation, particularly affecting the expression of short-lived genes that are rapidly induced and are essential for cell proliferation and survival. Many of these genes are oncogenes or other genes critical for cancer cell growth. Selective Impact on Cancer Cells: Cancer cells are often more dependent on such rapidly induced genes for their survival and proliferation compared to normal cells. Therefore, CDK9 inhibitors like KB-0742 can disproportionately affect cancer cells by inhibiting their ability to sustain necessary gene expression levels, leading to impaired growth and induction of apoptosis (programmed cell death).

User Image Digital_Waffle_Pirate Posted - 1 day ago

$KRON This is a very good/supportive paper, worth anyone's time who cares. TL:DR - KB-0742 disrupts RNA splicing, causing an accumulation of mis-spliced RNA that triggers protein kinase R (PKR), a double-stranded RNA sensor. As PKR activates, it initiates immune pathways akin to those used to fight viral infections. End result is that it targets cancer cells, and also boosts immune response.

User Image RallyRaider Posted - 1 day ago

$KRON Dear KRONIES It took me a while--- You get the science and thus ignore the business side. Some of the stuff regarding portfolio management, corporate and value creation is SUCH absolute nonsense,, it shocks me that you invest based upon these premises. https://www.youtube.com/playlist?list=PL8FB14A2200B87185 Please take a deeper look instead of trying to unveil the 19th aspect of some hidden agenda.

User Image KavaStocks Posted - 1 day ago

$KRON These MMs are starting to get cute with hovering it around 1.00. They're continuing to weigh the R/R of bringing it lower but they're idling heavily on indecision. Buy some shares, Norbert.

User Image TheGhostOfEd Posted - 1 day ago

$KRON https://faseb.onlinelibrary.wiley.com/doi/10.1096/fj.202302375R

User Image StockAuthority Posted - 1 day ago

$POAI 37% in a day since my alert! Keep an eye on $EMKR $NUKK $KRON for more like this!

User Image StockAuthority Posted - 1 day ago

$KRON will you be in when the 13G hits??? :-)

User Image GPS_OS_21_vs_SOC_5 Posted - 1 day ago

$SLS Time for the Regular Reminder, Bill William Walker, aka @telomerase not only is a Lying Scumbag, but it is also a reliable, contrarian indicator, when its posting, the share price always Climbs. Here you can see bill William lying on yahoo, about 009 being "just as toxic" and "cured lied again' on the day SLS published Key Safety data showing 009 is the First Ever Safe CDK9 Inhibitor - and then, in the second screen shot, you see the liar lying about his earlier lies. $VINC $CADL $MAIA $KRON @kubota2323 @peapope @rustycat @SuperTed182 now you know

User Image StockAuthority Posted - 1 day ago

$KRON OK so now this is a data runup play into ASCO AND a 13G expected play.

User Image StockAuthority Posted - 1 day ago

$KRON strong green today despite market dip. I was actually hoping to load more at .95 :-(

User Image HamburgerTim Posted - 2 days ago

$KRON are we expecting much from ER? I figure flat/non event.

User Image Digital_Waffle_Pirate Posted - 2 days ago

$KRON Former long time colleague of Angela Koehler, now CSO of Amgen, ostensibly the most vocal about undruggable targets among the major pharmas.

User Image Digital_Waffle_Pirate Posted - 2 days ago

$KRON 80mg old schedule data will prove out the why for the new schedule. https://ir.kronosbio.com/news-releases/news-release-details/kronos-bio-present-clinical-update-phase-12-trial-kb-0742-2024

User Image wolfywolfy13 Posted - 2 days ago

$KRON 👀

User Image Stock_Titan Posted - 2 days ago

$KRON Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting https://www.stocktitan.net/news/KRON/kronos-bio-to-present-clinical-update-on-phase-1-2-trial-of-kb-0742-a5dwom0flt00.html

User Image KavaStocks Posted - 2 days ago

$KRON A close at or above 1.00 would be welcome. Can we move on from these fractionals, MMs?

User Image Digital_Waffle_Pirate Posted - 2 days ago

$KRON June 1, 9AM - a Saturday.

User Image Digital_Waffle_Pirate Posted - 2 days ago

$KRON ASCO it is.

User Image BiotechValues Posted - 2 days ago

$KRON data update at ASCO

User Image XInFaMoUzZNaSxX Posted - 3 days ago

$KRON back in. new avg .986

User Image LetsgoDudeszi Posted - 3 days ago

$KRON This one catching eyes, Soon push back to 1.40 !! Earnings in 14 days.

User Image telomerase Posted - 3 days ago

$KRON CADL has already recovered my KRON losses and more. Oncolytic viruses* are the future (yes, there will be that one zombie plague, but look at Rwanda, Pol Pot, Chicago etc.... humans are basically zombies anyway). *yes, yes, CAN-2049 is a vector. At least CADL uses DNA viruses instead of the mutating RNA crap that we had in the BL3 at Mayo. I'm still suprised that I'm not GFP green.

User Image LetsgoDudeszi Posted - 3 days ago

$KRON back over 1 incoming !!

Analyst Ratings
Piper Sandler Overweight Dec 19, 23
HC Wainwright & Co. Buy Dec 19, 23
HC Wainwright & Co. Buy Nov 27, 23
HC Wainwright & Co. Buy Aug 21, 23
HC Wainwright & Co. Buy Apr 17, 23
HC Wainwright & Co. Buy Nov 18, 22
Goldman Sachs Buy Nov 10, 22
Piper Sandler Overweight Nov 9, 22
Berenberg Buy Sep 14, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dinsmore Christopher Chief Scientific Off.. Chief Scientific Officer Jan 04 Sell 1.1836 7,366 8,718 260,969 01/05/24
DiMartino Jorge Chief Medical Office.. Chief Medical Officer & VP Jan 04 Sell 1.1836 12,009 14,214 315,246 01/05/24
Kosacz Barbara COO & General Counse.. COO & General Counsel Jan 04 Sell 1.1836 10,676 12,636 928,966 01/05/24
BISCHOFBERGER NORBERT W President & CEO President & CEO Nov 15 Buy 0.96 1,731,056 1,661,814 2,540,665 11/17/23
Dinsmore Christopher Chief Scientific Off.. Chief Scientific Officer Feb 24 Sell 1.7355 6,291 10,918 285,001 02/24/23
DiMartino Jorge Chief Medical Office.. Chief Medical Officer & VP Feb 24 Sell 1.7355 10,153 17,621 355,440 02/24/23
Al-Wakeel Yasir B. Chief Financial Offi.. Chief Financial Officer Feb 24 Sell 1.7355 9,026 15,665 355,719 02/24/23
BISCHOFBERGER NORBERT W President & CEO President & CEO May 17 Buy 3.78 597,129 2,257,148 809,609 05/19/22